Recent Posts on This Topic | See All >
[Source: New York Times] - Before StriVectin’s stretch-mark cream became an anti-wrinkle blockbuster sold in Sephora and Bloomingdale’s, it made its debut in 2002 at GNC, a retailer better known for its muscle-building supplements.
Then in 2003, StriVectin started running print ads with the alluring claim that women who used the cream ($135 a tube) as a facial moisturizer found it reduced their wrinkles. The ads asked: Could StriVectin actually be “Better than Botox?”
For more information: Debating the Claims Behind Wrinkle Creams
“Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade. Also, discover The State of Bioscience.